(Q39119851)

9 September 2017

Sustainability, affordability, and equity of corporate drug donations: the case of Malarone (English)

1 reference

9 September 2017

1 reference

4

1 reference

9 September 2017

R Brugha

2

0 references

author name string

R Shretta

series ordinal

1

1 reference

PubMed ID

10905260

9 September 2017

A Robb

series ordinal

3

1 reference

PubMed ID

10905260

9 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

9 September 2017

1 reference

9 September 2017

355

1 reference

9 September 2017

9216

1 reference

9 September 2017

1718-1720

1 reference

The "roll back malaria" campaign

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902251-0

7 January 2021

Malarone-donation programme in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902251-0

7 January 2021

Malarone-donation programme in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902251-0

7 January 2021

Malarone-donation programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902251-0

7 January 2021

Models to predict the intensity of Plasmodium falciparum transmission: applications to the burden of disease in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902251-0

7 January 2021

Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902251-0

7 January 2021

10.1016/S0140-6736(00)02251-0

Identifiers

DOI

1 reference

9 September 2017

1 reference

PubMed ID

10905260